AccessPak for HIV PEP Expanded with Viracept and Incruse Ellipta
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Indacaterol
- AccessPak for HIV PEP Expanded with Viracept-Indacaterol and Glycopyrrolate
- AccessPak for HIV PEP Expanded with Viracept-Indacaterol and glycopyrrolate Inhalation
- AccessPak for HIV PEP Expanded with Viracept-Indacaterol inhalation
- AccessPak for HIV PEP Expanded with Viracept-Indacaterol Maleate
- AccessPak for HIV PEP Expanded with Viracept-Indapamide
- Incruse Ellipta-Accolate
- Incruse Ellipta-Accretropin
- Incruse Ellipta-Accucaine
- Incruse Ellipta-AccuHist Drops
- Incruse Ellipta-AccuHist PDX Drops
- Incruse Ellipta-AccuHist PDX Syrup